3.89
전일 마감가:
$3.98
열려 있는:
$3.95
하루 거래량:
2.31M
Relative Volume:
0.53
시가총액:
$383.48M
수익:
$775.09M
순이익/손실:
$-58.68M
주가수익비율:
-29.34
EPS:
-0.1326
순현금흐름:
$64.06M
1주 성능:
-6.04%
1개월 성능:
-5.81%
6개월 성능:
-10.98%
1년 성능:
-41.15%
Goodrx Holdings Inc Stock (GDRX) Company Profile
명칭
Goodrx Holdings Inc
전화
(855) 268-2822
주소
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GDRX
Goodrx Holdings Inc
|
3.89 | 1.38B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
289.84 | 46.86B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.10 | 16.06B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.91 | 12.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
96.00 | 8.02B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.52 | 7.05B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-10 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-07-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 개시 | Citigroup | Buy |
| 2022-11-04 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-12 | 개시 | DA Davidson | Neutral |
| 2022-06-10 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-06 | 재개 | BofA Securities | Buy |
| 2022-06-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Equal Weight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 재확인 | Barclays | Overweight |
| 2022-03-01 | 재확인 | BofA Securities | Neutral |
| 2022-03-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-03-01 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 재확인 | Evercore ISI | Outperform |
| 2022-03-01 | 재확인 | Goldman | Buy |
| 2022-03-01 | 재확인 | JP Morgan | Underweight |
| 2022-03-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-03-01 | 재확인 | SVB Leerink | Outperform |
| 2022-01-07 | 개시 | Goldman | Buy |
| 2021-12-21 | 개시 | Stephens | Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-08-31 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-08-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-06 | 재개 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Guggenheim | Buy |
| 2020-11-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 개시 | Barclays | Equal Weight |
| 2020-10-19 | 개시 | BofA Securities | Neutral |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-10-19 | 개시 | Credit Suisse | Outperform |
| 2020-10-19 | 개시 | Deutsche Bank | Hold |
| 2020-10-19 | 개시 | Goldman | Neutral |
| 2020-10-19 | 개시 | JP Morgan | Neutral |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
| 2020-10-19 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 개시 | SVB Leerink | Outperform |
| 2020-10-19 | 개시 | UBS | Buy |
모두보기
Goodrx Holdings Inc 주식(GDRX)의 최신 뉴스
Real time breakdown of GoodRx Holdings Inc. stock performance2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Is GoodRx Holdings Inc. still worth holding after the dipTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaPortfolio Gains Summary & Daily Price Action Insights - newser.com
What Fibonacci levels say about GoodRx Holdings Inc. reboundJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying' - Benzinga
Reversal indicators forming on GoodRx Holdings Inc. stockEarnings Summary Report & AI Driven Price Predictions - newser.com
Weighing GoodRx After 92% Five Year Slide and Walgreens Dispute News - Yahoo Finance
Published on: 2025-10-20 09:31:37 - newser.com
How analysts rate GoodRx Holdings Inc. stock todayJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
GoodRx (GDRX): Evaluating Valuation as Shares Face Prolonged Slump in Healthcare Services Sector - Yahoo Finance
GoodRx Holdings Inc Stock Analysis and ForecastEvening Star Patterns & Affordable Market Insights - earlytimes.in
Real time social sentiment graph for GoodRx Holdings Inc.Weekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Institutional scanner results for GoodRx Holdings Inc.Weekly Trading Summary & Real-Time Volume Trigger Notifications - newser.com
GDRXGoodrx Holdings, Inc. Latest Stock News & Market Updates - Stock Titan
How sentiment analysis helps forecast GoodRx Holdings Inc.Layoff News & Free Technical Confirmation Trade Alerts - newser.com
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Edwards Lifesciences (EW) - The Globe and Mail
How to use a screener to detect GoodRx Holdings Inc. breakouts2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
GoodRx (GDRX) Launches Affordable Hair Loss Treatment Subscripti - GuruFocus
GoodRx launches subscription program for men's hair loss - Seeking Alpha
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment - Stock Titan
Can trapped investors hope for a rebound in GoodRx Holdings Inc.Market Trend Summary & Verified Entry Point Detection - newser.com
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 29% Potential Upside for Savvy Investors - DirectorsTalk Interviews
3 Cash-Producing Stocks with Warning Signs - The Globe and Mail
GoodRx Holdings, Inc.Class A Common Stock (NQ: - FinancialContent
Why GoodRx Holdings Stock Was Sinking This Week - MSN
Will GoodRx Holdings Inc. stock recover after recent dropTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
GDRX (GoodRx Holdings) Cash Flow for Dividends : $0.0 Mil (TTM As of Jun. 2025) - GuruFocus
GoodRx (NASDAQ:GDRX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Up 10.5%Here's Why - MarketBeat
How Product Roadmap Could Affect Surana Telecom and Power Limiteds Future ValueVolatility Index Analysis & Low Entry Risk Stocks - earlytimes.in
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - The Globe and Mail
GoodRx: Novo Deal And TrumpRx Talks Point To EBITDA/FCF Upside (NASDAQ:GDRX) - Seeking Alpha
Price action breakdown for GoodRx Holdings Inc.Quarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
What technical models suggest about GoodRx Holdings Inc.’s comebackPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Goodrx Holdings Inc (GDRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):